sante.fr vaccination 75 ans - dofaq.co
Manufacturing Consent for Vaccine Mandates: A Comparative Case Study of Communication Campaigns in France and Australia
Frontiers - 26 Jun 2024
Manufacturing Consent for Vaccine Mandates: A Comparative Case Study of Communication Campaigns in France and Australia ...
Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis
Nature.com - 05 Sep 2024
Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis ...
Association between Pandemic of COVID-19 and Influenza Vaccine Take-Up in 2020–2021 in Maine et Loire (France)
Wiley Online Library - 25 Jul 2024
Association between Pandemic of COVID-19 and Influenza Vaccine Take-Up in 2020–2021 in Maine et Loire (France) ...
RSV infection vaccination recommendation for pregnant women - Haute Autorité de Santé
HAS - 13 Jun 2024
RSV infection vaccination recommendation for pregnant women ...
French health authority recommends anti-bronchitis vaccine for over 75s
The Connexion - 04 Jul 2024
French health authority recommends anti-bronchitis vaccine for over 75s ...
Understanding the gap between guidelines and influenza vaccination coverage in people with diabetes: a scoping review
Frontiers - 19 Apr 2024
Understanding the gap between guidelines and influenza vaccination coverage in people with diabetes: a scoping review ...
COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhône-Alpes region (France): An ecological study
ScienceDirect.com - 31 Jan 2022
COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhône-Alpes region (France): An ecological study ...
Public health milestones through the years
World Health Organization - 03 Apr 2023
Public health milestones through the years ...
From a voluntary vaccination policy to mandatory vaccination against COVID-19 in cancer patients: an empirical and interdisciplinary study in bioethics
BMC Medical Ethics - 28 Aug 2022
From a voluntary vaccination policy to mandatory vaccination against COVID-19 in cancer patients: an empirical and interdisciplinary study in bioethics ...
Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna
The Lancet - 14 Nov 2022
Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna ...
When Lack of Trust in the Government and in Scientists Reinforces Social Inequalities in Vaccination Against COVID-19
Frontiers - 22 Feb 2024
When Lack of Trust in the Government and in Scientists Reinforces Social Inequalities in Vaccination Against COVID-19 ...
(PDF) Context matters: How to research vaccine attitudes and uptake after the COVID-19 crisis
ResearchGate - 28 Jun 2024
(PDF) Context matters: How to research vaccine attitudes and uptake after the COVID-19 crisis ...
ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling
ScienceDirect.com - 22 Dec 2020
ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling ...
Influenza vaccination coverage of professionals working in nursing homes in France and related determinants, 2018–2019 season: a cross-sectional survey
BMC Public Health - 25 May 2022
Influenza vaccination coverage of professionals working in nursing homes in France and related determinants, 2018–2019 season: a cross-sectional survey ...
Psychometric validation of a 7C-model of antecedents of vaccine acceptance among healthcare workers, parents and adolescents in France | Scientific Reports
Nature.com - 14 Nov 2023
Psychometric validation of a 7C-model of antecedents of vaccine acceptance among healthcare workers, parents and adolescents in France | Scientific Reports ...
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
The Lancet - 31 Jan 2022
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study ...
Contributions of cost-effectiveness analyses (CEA) to influenza vaccination policy for older adults in Europe
ScienceDirect.com - 31 Aug 2023
Contributions of cost-effectiveness analyses (CEA) to influenza vaccination policy for older adults in Europe ...
Vaccination perception and coverage among healthcare students in France in 2019
BMC Medical Education - 14 Dec 2020
Vaccination perception and coverage among healthcare students in France in 2019 ...
Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population
Nature.com - 21 May 2022
Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population ...